NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

全球傳染病診斷市場:按產品/解決方案(消耗品,診斷設備,軟件服務),按技術(免疫診斷,PCR,INAAT),按疾病(HIV,醫院感染,流行性感冒),按最終用戶(醫院),參考實驗室,研究所)未來預測(至2027年)

Infectious Disease Diagnostics Market by Product and Solution (Consumables, System, Software & Services), Technology (Immunodiagnostics, PCR, INAAT), Disease (HIV, HAIS, Influenza), End User (Hospital, Reference Lab, Research) - Global Forecast to 2027

出版商 Meticulous Market Research Pvt. Ltd. 商品編碼 995749
出版日期 內容資訊 英文 200 Pages
訂單完成後即時交付
價格
全球傳染病診斷市場:按產品/解決方案(消耗品,診斷設備,軟件服務),按技術(免疫診斷,PCR,INAAT),按疾病(HIV,醫院感染,流行性感冒),按最終用戶(醫院),參考實驗室,研究所)未來預測(至2027年) Infectious Disease Diagnostics Market by Product and Solution (Consumables, System, Software & Services), Technology (Immunodiagnostics, PCR, INAAT), Disease (HIV, HAIS, Influenza), End User (Hospital, Reference Lab, Research) - Global Forecast to 2027
出版日期: 2021年03月12日內容資訊: 英文 200 Pages
簡介

2020年至2027年,全球傳染病診斷市場預計將以6.9%的複合年增長率增長,到2027年將達到428.5億美元。

市場的主要推動力是各種傳染病(COVID-19,埃博拉,豬流感等)在世界範圍內的傳播,增加了對傳染病診斷研究的資金以及從集中化測試的多樣化,其中包括向護理類型(PoC)測試,對基因組學和蛋白□□質組學的需求增加以及新興市場的增長。

按產品/解決方案而言,消耗品是最大的細分市場。特別地,對可以在短時間內診斷出各種疾病的診斷試劑盒和試劑的需求不斷增長。

按技術,對免疫診斷的需求最大。

按疾病類型劃分,對肝炎的需求佔最大份額。

按地區劃分,北美國家是最大的市場,其次是歐洲國家,亞太地區國家,拉丁美洲國家和中東/非洲國家。另一方面,預計未來亞太地區國家市場將快速增長。

本報告分析了全球感染控制市場,包括市場的基本結構,主要的促銷/抑制因素,總體市場趨勢展望(到2027年),產品/服務,技術和疾病,我們正在通過以下方式調查詳細趨勢:類型,最終用戶和地區,最近的市場競爭和戰略發展趨勢以及主要公司的概況。

目錄

第1章簡介

第2章分析方法

第3章執行摘要

第4章市場考慮

  • 市場概況
  • 市場推廣因素
    • 傳染病患病率上升
    • 對早期疾病診斷的興趣日益濃厚
    • 新的冠狀病毒感染(COVID-19)的影響
    • 傳染病診斷研究活動的經費籌措
    • 將重點從實驗室的集中測試轉移到POC測試服務
  • 市場抑制因素
    • 不利和不足的贖回方案
  • 市場機會
    • 基因組學和蛋白□□質組學的進展
    • 對個性化醫學的興趣日益濃厚
    • 新興國家
  • 挑戰
    • 缺乏對特定症狀的認識和對新感染的診斷

第5章全球傳染病診斷市場:按產品/服務

  • 簡介
  • 消耗品
  • 診斷設備
  • 軟件服務

第6章全球傳染病診斷市場:按技術

  • 簡介
  • 免疫診斷
  • 臨床微生物診斷
  • 聚合□鏈反應(PCR)
  • 等溫核酸擴增技術(INAAT)
  • DNA測序和下一代測序(NGS)
  • DNA微陣列
  • 其他技術

第7章全球傳染病診斷市場:按疾病類型劃分

  • 簡介
  • 肝炎
  • 人類免疫缺陷病毒(HIV)
  • 醫院感染(HAI)
  • 人乳頭瘤病毒(HPV)
  • 結核(TB)
  • 流行性感冒
  • 其他傳染病

第8章全球傳染病診斷市場:按最終用戶分類

  • 簡介
  • 診斷實驗室
  • 醫院/臨床實驗室
  • 教育研究所
  • 其他最終用戶

第9章全球傳染病診斷市場:按地區

  • 簡介
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 意大利
    • 法國
    • 英國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 其他亞太國家
  • 拉丁美洲
  • 中東/非洲

第10章競爭情況

  • 簡介
  • 主要增長策略
  • 公司之間的比較分析
  • 市場份額分析(2019)
    • F. Hoffmann-La Roche Ltd.
    • Abbott Laboratories
    • Danaher Corporation

第11章公司簡介(業務概覽,主要財務指標,產品組合,戰略發展狀況)

  • Abbott Laboratories
  • Danaher Corporation
  • Bio-Rad Laboratories, Inc.
  • Biomerieux S.A.
  • F. Hoffmann-La Roche, Ltd.
  • Becton, Dickinson and Company
  • DiaSorin S.P.A.
  • Meridian Bioscience, Inc.
  • Quidel Corporation
  • Thermo Fisher Scientific, Inc.

第12章附錄

目錄

Infectious Disease Diagnosis Market by Product & Solution (Consumables, System, Software & Services), Technology (Immunodiagnostics, PCR, INAAT), Disease (HIV, HAIS, Influenza), End User (Hospital, Reference Lab, Research) - Forecast to 2027

The global infectious disease diagnosis market is expected to grow at a CAGR of 6.9% from 2020 to 2027 to reach $42.85 billion by 2027.

Succeeding an extensive secondary and primary research and in-depth analysis of the market scenario, the report carries out the in-depth analysis on key industry drivers, restraints, challenges, and opportunities. The growth in the infectious disease diagnosis market is mainly attributed to the increasing global prevalence of infectious diseases such as COVID-19, Ebola, and Swine Flu, among others; growing awareness for early detection using specific diagnostic tests; growth in funding for research on infectious disease diagnostics; and shift in focus from centralized laboratories to decentralized point-of-care testing services. Moreover, advances in genomics and proteomics and emerging countries provide increasing growth opportunities for players operating in the infectious disease diagnosis market.

The infectious disease diagnosis market study presents historical market data in terms of value (2018, and 2019), estimated current data (2020), and forecasts for 2027 - by product & solution, technology, disease type, and end user. The study also evaluates industry competitors and analyzes the market at regional and country level.

Based on products & solutions, the consumables segment is estimated to hold the largest share of the overall infectious disease diagnosis market in 2020. The large share of this segment is mainly attributed to the increasing prevalence of infectious diseases, rising awareness among the population to identify the diseases, and increasing use of kits and reagents to identify the organism causing various diseases in lesser time and cost.

On the basis of technology, the immunodiagnostics segment is estimated to account for the largest share of the overall market in 2020. Increasing use of immunoassays in infectious disease testing, development of novel tests, rising trend of automation, increasing awareness about the health and fitness, and reduced complications associated with the instruments are some of the major factors driving the growth of this market.

On the basis of disease type, the hepatitis diseases segment is estimated to hold the largest share of the market in 2020. Increasing number of blood transfusions and donations, increasing prevalence of hepatitis B & C infections, rising susceptibility of the geriatric population, growing awareness among the population, and benefits offered by point of care instruments & kits are expected to propel the growth of this segment.

An in-depth analysis of the geographical scenario of the infectious disease diagnosis market provides detailed qualitative and quantitative insights about the five major geographies (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa) along with the coverage of major countries in each region. North America region is estimated to command the largest share of the overall infectious disease diagnosis market in 2020, followed by Europe, Asia-Pacific, Latin America, and Middle East & Africa. However, Asia Pacific region is slated to register the highest growth during the forecast period primarily due to the rapid urbanization, increasing investments by healthcare providers towards infrastructure improvement, need to manage growing burden of infectious diseases, and government efforts to improve the accessibility of diagnostic services to enhance the prevention by developing products or platforms required for the diagnosis of infectious diseases.

The key players operating in the global infectious disease diagnosis market are Abbott Laboratories (U.S.), Danaher Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.), bioMerieux S.A. (France), Thermo Fisher Scientific (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Becton, Dickinson and Company (U.S.), DiaSorin S.p.A. (Italy), Meridian Bioscience Inc. (U.S.), and Quidel Corporation (U.S.).

Scope of the Report:

Market, by Product & Solutions

  • Consumables
  • Instruments
  • Software & Services

Market, by Technology

  • Immunodiagnostics
  • Clinical Microbiology
  • Polymerase Chain Reaction
  • Isothermal Nucleic Acid Amplification Technology
  • DNA Sequencing and Next-Generation Sequencing (NGS)
  • DNA Microarray Technology
  • Other technologies

Other Technologies comprises of microscopy, hybridization, and loop-mediated isothermal amplification

Market, by Disease Type

  • Hepatitis
  • Human Immunodeficiency Virus (HIV)
  • Hospital-Acquired Infections (HAIS)
  • Human Papillomavirus (HPV)
  • Tuberculosis (TB)
  • Influenza
  • Other Diseases

Other diseases comprise of measles, small pox, mumps, typhoid fever, malaria, meningitis, Ebola virus disease, Lyme disease, coronavirus disease, and whooping cough.

Market, by End Users

  • Hospital/Clinical Laboratories
  • Reference Laboratories
  • Academics/Research Institutes
  • Other End Users

Other end users comprise of physician offices, nursing facilities, and home healthcare agencies

Market, by Geography

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
  • Japan
  • China
  • India
  • Rest of APAC (RoAPAC)
  • Latin America
  • Middle East & Africa

TABLE OF CONTENTS

1. Introduction

  • 1.1. Market Definition
  • 1.2. Market Ecosystem
  • 1.3. Currency
  • 1.4. Key Stakeholders

2. Research Methodology

  • 2.1. Research Process
  • 2.2. Data Collection & Validation
    • 2.2.1. Secondary Research
    • 2.2.2. Primary Research
  • 2.3. Market Assessment
    • 2.3.1. Market Size Estimation
      • 2.3.1.1. Bottom-Up Approach
      • 2.3.1.2. Top-Down Approach
      • 2.3.1.3. Growth forecast
    • 2.3.2. Market Share Analysis
  • 2.4. Assumptions for the Study
  • 2.5. Limitations for the Study

3. Executive Summary

4. Market Insights

  • 4.1. Market Overview
  • 4.2. Drivers
    • 4.2.1. Increasing Prevalence of Infectious Diseases
    • 4.2.2. Growing Awareness of Early Disease Diagnosis
    • 4.2.3. Impact of Covid-19
    • 4.2.4. Rising Funds for Infectious Disease Diagnostics Research Activities
    • 4.2.5. Shift in Focus from Centralized Laboratories to POC Testing Services
  • 4.3. Restraints
    • 4.3.1. Unfavorable and Inadequate Reimbursement Scenario
  • 4.4. Opportunities
    • 4.4.1. Advances in Genomics and Proteomics
    • 4.4.2. Growing Awareness about Personalized Medicine
    • 4.4.3. Emerging Economies
  • 4.5. Challenges
    • 4.5.1. Lack of Awareness of Specific Symptoms and Diagnosis of Emerging Infections

5. Global Infectious Disease Diagnostics Market, by Product & Service

  • 5.1. Introduction
  • 5.2. Consumables
  • 5.3. Instruments
  • 5.4. Software & Services

6. Global Infectious Disease Diagnostics Market, by Technology

  • 6.1. Introduction
  • 6.2. Immunodiagnostics
  • 6.3. Clinical Microbiology
  • 6.4. Polymerase Chain Reaction (PCR)
  • 6.5. Isothermal Nucleic Acid Amplification Technology (INAAT)
  • 6.6. DNA Sequencing and Next-Generation Sequencing (NGS)
  • 6.7. DNA Microarray
  • 6.8. Other Technologies

7. Global Infectious Disease Diagnostics Market, by Disease Type

  • 7.1. Introduction
  • 7.2. Hepatitis
  • 7.3. Human Immunodeficiency Virus (HIV)
  • 7.4. Hospital-Acquired Infections (HAIs)
  • 7.5. Human Papillomavirus (HPV)
  • 7.6. Tuberculosis (TB)
  • 7.7. Influenza
  • 7.8. Other Infectious Diseases

8. Global Infectious Disease Diagnostics Market, by End User

  • 8.1. Introduction
  • 8.2. Diagnostic Reference Laboratories
  • 8.3. Hospital & Clinical Laboratories
  • 8.4. Academic & Research Institutes
  • 8.5. Other End Users

9. Global Infectious Disease Diagnostics Market, by Geography

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. U.S.
    • 9.2.2. Canada
  • 9.3. Europe
    • 9.3.1. Germany
    • 9.3.2. Italy
    • 9.3.3. France
    • 9.3.4. U.K.
    • 9.3.5. Spain
    • 9.3.6. Rest of Europe (RoE)
  • 9.4. Asia-Pacific
    • 9.4.1. Japan
    • 9.4.2. China
    • 9.4.3. India
    • 9.4.4. Rest of Asia-Pacific (RoAPAC)
  • 9.5. Latin America
  • 9.6. Middle East & Africa

10. Competitive Landscape

  • 10.1. Introduction
  • 10.2. Key Growth Strategies
  • 10.3. Competitive Benchmarking
  • 10.4. Market Share Analysis (2019)
    • 10.4.1. F. Hoffmann-La Roche Ltd.
    • 10.4.2. Abbott Laboratories
    • 10.4.3. Danaher Corporation

11. Company Profiles (Business Overview, Financial Overview, Product Portfolio and Strategic Developments)

  • 11.1. Abbott Laboratories
  • 11.2. Danaher Corporation
  • 11.3. Bio-Rad Laboratories, Inc.
  • 11.4. Biomerieux S.A.
  • 11.5. F. Hoffmann-La Roche, Ltd.
  • 11.6. Becton, Dickinson and Company
  • 11.7. DiaSorin S.P.A.
  • 11.8. Meridian Bioscience, Inc.
  • 11.9. Quidel Corporation
  • 11.10. Thermo Fisher Scientific, Inc.

12. Appendix

  • 12.1. Questionnaire
  • 12.2. Available Customization

List of Tables

  • Table 1 Global Infectious Disease Diagnostics Market Drivers: Impact Analysis (2020-2027)
  • Table 2 Covid 19 Confirmed Cases and Deaths across the World (2nd May 2020)
  • Table 3 Recent Diagnostic Tests Launched for Covid-19
  • Table 4 Global Infectious Disease Diagnostics Market Restraints: Impact Analysis (2020-2027)
  • Table 5 Clinical Applications of Infectious Disease Genomics and Proteomics
  • Table 6 Global Infectious Disease Diagnostics Market Size, by Product & Service, 2018-2027 ($Million)
  • Table 7 Recent Launches and Approvals in the Consumables Market
  • Table 8 Key Companies offering Infectious Disease Diagnostic Consumables
  • Table 9 Global Infectious Disease Diagnostic Consumables Market Size, by Country/Region, 2018-2027 ($ Million)
  • Table 10 Key Companies offering Infectious Disease Diagnostic Instruments
  • Table 11 Global Infectious Disease Diagnostic Instruments Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 12 Key Companies offering Infectious Disease Diagnostic Software and Services
  • Table 13 Global Infectious Disease Diagnostic Software & Services Market Size, by Country/Region, 2018-2027 ($ Million)
  • Table 14 Global Infectious Disease Diagnostics Market Size, by Technology, 2018-2027 ($ Million)
  • Table 15 Key Companies offering Immunodiagnostic-Based Products
  • Table 16 Global Immunodiagnostic-Based Infectious Disease Diagnostics Market Size, by Country/Region, 2018-2027 ($ Million)
  • Table 17 Global Clinical Microbiology-Based Infectious Disease Diagnostics Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 18 Key Companies offering PCR-Based Products
  • Table 19 Global PCR-Based Infectious Disease Diagnostics Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 20 Global INAAT-Based Infectious Disease Diagnostics Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 21 Global DNA Sequencing and NGS-Based Infectious Disease Diagnostics Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 22 Global DNA Microarray-Based Infectious Disease Diagnostics Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 23 Global Infectious Disease Diagnostics Market Size for Other Technologies, by Country/Region, 2018-2027 ($Million)
  • Table 24 Global Infectious Disease Diagnostics Market Size, by Disease Type, 2018-2027 ($Million)
  • Table 25 Global Infectious Disease Diagnostics Market Size for Hepatitis, by Country/Region, 2018-2027 ($Million)
  • Table 26 Key Players offering HIV Diagnostic Products
  • Table 27 Global Infectious Disease Diagnostics Market Size for HIV, by Country/Region, 2018-2027 ($Million)
  • Table 28 Global Infectious Disease Diagnostics Market Size for HAIs, by Country/Region, 2018-2027 ($Million)
  • Table 29 Global Infectious Disease Diagnostics Market Size for HPV, by Country/Region, 2018-2027 ($Million)
  • Table 30 Global Infectious Disease Diagnostics Market Size for Tuberculosis, by Country/Region, 2018-2027 ($Million)
  • Table 31 Some of the FDA-Cleared Nucleic Acid Detection-Based Tests for Influenza (2019)
  • Table 32 Global Infectious Disease Diagnostics Market Size for Influenza, by Country, 2018-2027 ($Million)
  • Table 33 Covid 19 Confirmed Cases and Deaths across the World (2nd May 2020)
  • Table 34 Diagnostic Tests for Covid-19
  • Table 35 Global Infectious Disease Diagnostics Market Size for Other Infectious Diseases, by Country, 2018-2027 ($ Million)
  • Table 36 Global Infectious Disease Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 37 Global Infectious Disease Diagnostics Market Size for Diagnostic Reference Laboratories, by Country, 2017-2027 ($Million)
  • Table 38 Global Infectious Disease Diagnostics Market Size for Hospital & Clinical Laboratories, by Country, 2018-2027 ($ Million)
  • Table 39 Global Infectious Disease Diagnostics Market Size for Academic & Research Institutes, by Country, 2017-2027 ($Million)
  • Table 40 Global Infectious Disease Diagnostics Market Size for Other End Users, by Country, 2017-2027 ($Million)
  • Table 41 Global Infectious Disease Diagnostics Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 42 North America: Infectious Disease Diagnostics Market Size, by Country, 2018-2027 ($Million)
  • Table 43 North America: Infectious Disease Diagnostics Market Size, by Product & Service, 2018-2027 ($Million)
  • Table 44 North America: Infectious Disease Diagnostics Market Size, by Technology, 2018-2027 ($Million)
  • Table 45 North America: Infectious Disease Diagnostics Market Size, by Disease Type, 2018-2027 ($Million)
  • Table 46 North America: Infectious Disease Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 47 U.S.: Disease Rate and Number of New Cases (2016 & 2017)
  • Table 48 U.S.: Infectious Disease Diagnostics Market Size, by Product & Service, 2018-2027 ($Million)
  • Table 49 U.S.: Infectious Disease Diagnostics Market Size, by Technology, 2018-2027 ($Million)
  • Table 50 U.S.: Infectious Disease Diagnostics Market Size, by Disease Type, 2018-2027 ($Million)
  • Table 51 U.S.: Infectious Disease Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 52 Canada: Infectious Disease Diagnostics Market Size, by Product & Service, 2018-2027 ($Million)
  • Table 53 Canada: Infectious Disease Diagnostics Market Size, by Technology, 2018-2027 ($Million)
  • Table 54 Canada: Infectious Disease Diagnostics Market Size, by Disease Type, 2018-2027 ($Million)
  • Table 55 Canada: Infectious Disease Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 56 Europe: Infectious Disease Diagnostics Market Size, by Country, 2018-2027 ($Million)
  • Table 57 Europe: Infectious Disease Diagnostics Market Size, by Product & Service, 2018-2027 ($Million)
  • Table 58 Europe: Infectious Disease Diagnostics Market Size, by Technology, 2018-2027 ($Million)
  • Table 59 Europe: Infectious Disease Diagnostics Market Size, by Disease Type, 2018-2027 ($Million)
  • Table 60 Europe: Infectious Disease Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 61 Germany: HIV and AIDS Estimates (2018)
  • Table 62 Personalized therapies Authorized in Germany (2017)
  • Table 63 Germany: Infectious Disease Diagnostics Market Size, by Product & Service, 2018-2027 ($Million)
  • Table 64 Germany: Infectious Disease Diagnostics Market Size, by Technology, 2018-2027 ($Million)
  • Table 65 Germany: Infectious Disease Diagnostics Market Size, by Disease Type, 2018-2027 ($Million)
  • Table 66 Germany: Infectious Disease Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 67 Italy: Cancer Prevalence 2018
  • Table 68 Number of Cancer Cases, (2018 Vs 2040)
  • Table 69 Italy: Covid-19 Cases
  • Table 70 Italy: Infectious Disease Diagnostics Market Size, by Product & Service, 2018-2027 ($Million)
  • Table 71 Italy: Infectious Disease Diagnostics Market Size, by Technology, 2018-2027 ($Million)
  • Table 72 Italy: Infectious Disease Diagnostics Market Size, by Disease Type, 2018-2027 ($Million)
  • Table 73 Italy: Infectious Disease Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 74 France: Infectious Disease Diagnostics Market Size, by Product & Service, 2018-2027 ($Million)
  • Table 75 France: Infectious Disease Diagnostics Market Size, by Technology, 2018-2027 ($Million)
  • Table 76 France: Infectious Disease Diagnostics Market Size, by Disease Type, 2018-2027 ($Million)
  • Table 77 France: Infectious Disease Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 78 U.K.: Infectious Disease Diagnostics Market Size, by Product & Service, 2018-2027 ($Million)
  • Table 79 U.K.: Infectious Disease Diagnostics Market Size, by Technology, 2018-2027 ($Million)
  • Table 80 U.K.: Infectious Disease Diagnostics Market Size, by Disease Type, 2018-2027 ($Million)
  • Table 81 U.K.: Infectious Disease Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 82 Spain: Infectious Disease Diagnostics Market Size, by Product & Service, 2018-2027 ($Million)
  • Table 83 Spain: Infectious Disease Diagnostics Market Size, by Technology, 2018-2027 ($Million)
  • Table 84 Spain: Infectious Disease Diagnostics Market Size, by Disease Type, 2018-2027 ($Million)
  • Table 85 Spain: Infectious Disease Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 86 Hepatitis A Cases (2016 Vs.2017)
  • Table 87 Covid-19 Cases in European Countries
  • Table 88 Roe: Infectious Disease Diagnostics Market Size, by Product & Service, 2018-2027 ($Million)
  • Table 89 Roe: Infectious Disease Diagnostics Market Size, by Technology, 2018-2027 ($Million)
  • Table 90 Roe: Infectious Disease Diagnostics Market Size, by Disease Type, 2018-2027 ($Million)
  • Table 91 Roe: Infectious Disease Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 92 Asia-Pacific: Infectious Disease Diagnostics Market Size, by Country, 2018-2027 ($Million)
  • Table 93 Asia-Pacific: Infectious Disease Diagnostics Market Size, by Product & Service, 2018-2027 ($Million)
  • Table 94 Asia-Pacific: Infectious Disease Diagnostics Market Size, by Technology, 2018-2027 ($Million)
  • Table 95 Asia-Pacific: Infectious Disease Diagnostics Market Size, by Disease Type, 2018-2027 ($Million)
  • Table 96 Asia-Pacific: Infectious Disease Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 97 Japan: Percentage Geriatric Population (65 and Over)
  • Table 98 Japan: Infectious Disease Diagnostics Market Size, by Product & Service, 2018-2027 ($Million)
  • Table 99 Japan: Infectious Disease Diagnostics Market Size, by Technology, 2018-2027 ($Million)
  • Table 100 Japan: Infectious Disease Diagnostics Market Size, by Disease Type, 2018-2027 ($Million)
  • Table 101 Japan: Infectious Disease Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 102 China: Infectious Disease Diagnostics Market Size, by Product & Service, 2018-2027 ($Million)
  • Table 103 China: Infectious Disease Diagnostics Market Size, by Technology, 2018-2027 ($Million)
  • Table 104 China: Infectious Disease Diagnostics Market Size, by Disease Type, 2018-2027 ($Million)
  • Table 105 China: Infectious Disease Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 106 India: Infectious Disease Diagnostics Market Size, by Product & Service, 2018-2027 ($Million)
  • Table 107 India: Infectious Disease Diagnostics Market Size, by Technology, 2018-2027 ($Million)
  • Table 108 India: Infectious Disease Diagnostics Market Size, by Disease Type, 2018-2027 ($Million)
  • Table 109 India: Infectious Disease Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 110 RoAPAC: Infectious Disease Diagnostics Market Size, by Product & Service, 2018-2027 ($Million)
  • Table 111 RoAPAC: Infectious Disease Diagnostics Market Size, by Technology, 2018-2027 ($Million)
  • Table 112 RoAPAC: Infectious Disease Diagnostics Market Size, by Disease Type, 2018-2027 ($Million)
  • Table 113 RoAPAC: Infectious Disease Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 114 Latin America: Infectious Disease Diagnostics Market Size, by Product & Service, 2018-2027 ($Million)
  • Table 115 Latin America: Infectious Disease Diagnostics Market Size, by Technology, 2018-2027 ($Million)
  • Table 116 Latin America: Infectious Disease Diagnostics Market Size, by Disease Type, 2018-2027 ($Million)
  • Table 117 Latin America: Infectious Disease Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 118 EDCTP Funding for Infectious Disease Diagnostics (2003-2018)
  • Table 119 Middle East & Africa: Infectious Disease Diagnostics Market Size, by Product & Service, 2018-2027 ($Million)
  • Table 120 Middle East & Africa: Infectious Disease Diagnostics Market Size, by Technology, 2018-2027 ($Million)
  • Table 121 Middle East & Africa: Infectious Disease Diagnostics Market Size, by Disease Type, 2018-2027 ($Million)
  • Table 122 Middle East & Africa: Infectious Disease Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 123 Recent Developments, by Company, 2017-2020

List of Figures

  • Figure 1 Research Process
  • Figure 2 Key Secondary Sources
  • Figure 3 Primary Research Techniques
  • Figure 4 Key Executives Interviewed
  • Figure 5 Breakdown of Primary Interviews (Supply-Side & Demand-Side)
  • Figure 6 Market Size Estimation
  • Figure 7 Global Infectious Disease Diagnostics Market, by Product & Service, 2020 Vs. 2027 ($Million)
  • Figure 8 Global Infectious Disease Diagnostics Market Size, by Technology, 2020 Vs. 2027 ($Million)
  • Figure 9 Global Infectious Disease Diagnostics Market Size, by Disease Type, 2020 Vs. 2027 ($Million)
  • Figure 10 Diagnostic Reference Laboratories Are Expected to Dominate the Global Infectious Disease Diagnostics Market, by End User (2020-2027)
  • Figure 11 Infectious Disease Diagnostics Market, by Region
  • Figure 12 Market Dynamics
  • Figure 13 Global Infectious Disease Diagnostics Market Size, by Product & Service, 2020-2027 ($Million)
  • Figure 14 Global Infectious Disease Diagnostics Market Size, by Technology, 2020-2027 ($Million)
  • Figure 15 Global Infectious Disease Diagnostics Market Size, by Disease Type, 2020-2027 ($Million)
  • Figure 16 U.S.: Hospital-Acquired Infections
  • Figure 17 Tuberculosis R&D Funding (2015-2018)
  • Figure 18 Laboratory Confirmed Hospitalization Rate for Influenza, 2019-2020
  • Figure 19 Global Infectious Disease Diagnostics Market Size, by End User, 2020-2027 ($Million)
  • Figure 20 Tuberculosis R&D Funding (2015-2018)
  • Figure 21 Global Infectious Disease Diagnostics Market Size, by Geography, 2020-2027 ($Million)
  • Figure 22 North America: Infectious Disease Diagnostics Market Snapshot
  • Figure 23 U.S. Health Expenditure for Homecare Settings (2005-2017) (in $Billion)
  • Figure 24 Europe: Infectious Disease Diagnostics Market Snapshot
  • Figure 25 Germany: Infection Data, by Infection Site, 2010-2016 (%)
  • Figure 26 France: Percentage of Older People (65 Years and Above), 2010-2050
  • Figure 27 Asia-Pacific: Infectious Disease Diagnostics Market Snapshot
  • Figure 28 China: Geriatric Population (Million)
  • Figure 29 Coronavirus Outbreak in Latin America (6th May 2020)
  • Figure 30 Healthcare Expenditure in Latin America (2012-2016)
  • Figure 31 Key Growth Strategies Adopted by Leading Players, 2017-2020
  • Figure 32 Infectious Disease Diagnostics: Competitive Benchmarking
  • Figure 33 Market Share Analysis: Infectious Disease Diagnostics Industry, 2019
  • Figure 34 Abbott Laboratories: Financial Overview (2019)
  • Figure 35 Danaher Corporation: Financial Overview (2019)
  • Figure 36 Bio-Rad Laboratories, Inc.: Financial Overview (2019)
  • Figure 37 Biomerieux S.A.: Financial Overview (2018)
  • Figure 38 F. Hoffmann-La Roche, Ltd.: Financial Overview (2019)
  • Figure 39 Becton, Dickinson and Company: Financial Overview (2019)
  • Figure 40 DiaSorin S.P.A.: Financial Overview (2018)
  • Figure 41 Meridian Bioscience, Inc.: Financial Overview (2019)
  • Figure 42 Quidel Corporation: Financial Overview (2019)
  • Figure 43 Thermo Fisher Scientific, Inc.: Financial Overview (2019)